Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children
This economic evaluation found that for remission, both PPOIT and OIT were cost-effective and good value compared with no treatment, with OIT associated with a larger effect size but no clinically meaningful difference. When QALYs are prioritized, PPOIT offers the best value. Key factors associated with cost-effectiveness were treatment product pricing and patient quality of life.
Authors
- Melanie Lloyd (ORCID: https://orcid.org/0000-0002-3889-5458)
- Paxton Loke (ORCID: https://orcid.org/0000-0002-9474-083X)
- Kim Dalziel (ORCID: https://orcid.org/0000-0003-4972-8871)
- P. Quinn
- Mimi L. K. Tang
- Li Huang
- Michael Gold
- Adam Franz
- Michael O’Sullivan
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- University of South Australia (AU)
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Princess Margaret Hospital for Children (AU)
- Women's and Children's Hospital (AU)
- Monash Health (AU)
- Murdoch Children's Research Institute (AU)
- Melbourne Health (AU)
- The University of Adelaide (AU)
- Victoria University (AU)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-20
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.2410
- Primary Topic
- Food Allergy and Anaphylaxis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00